¼¶±ð: Ôº³¤
UID: 74482
¾«»ª: 0
·¢Ìû: 1326
ÍþÍû: 15 µã
»ý·Öת»»
ÓÞÓÞ±Ò: 1412 YYB
ÔÚÏß³äÖµ
¹±Ï×Öµ: 0 µã
ÔÚÏßʱ¼ä: 33(Сʱ)
×¢²áʱ¼ä: 2009-08-19
×îºóµÇ¼: 2022-08-22
Â¥Ö÷  ·¢±íÓÚ: 2017-08-08 10:32

 ¹ù¾ü½ÌÊÚ£º¡°ð롱Õß²»»ó£¡ÄÄÖÖðëÒ»¶¨ÒªÇеô£¿

Ƥ·ôÉϳ¤ð룬ÔÙÕý³£²»¹ýÁË¡£ÌرðÊÇÏÄÌ죬´©µÄÒ·þÉÙÁË£¬Ì«ÑôÓÖ¶¾£¬ÑÛ¾¦Ò»î©¾Í¿ÉÄÜ·¢Ïָ첲ÍÈÉ϶àÒ»¿ÅºÚðë¡£ÕâЩðëµ½µ×Òª²»Òª½ôÄØ?ʲôÑùµÄðë×îÈÝÒ×°©±ä?ÄÄЩºÚðëÒ»¶¨ÒªÇеô?´ø×ÅÕâЩÎÊÌ⣬ËѺü½¡¿µ¼ÇÕ߲ɷÃÁ˱±¾©´óѧÖ×ÁöÒ½Ôº¸±Ôº³¤¡¢ÖйúÁÙ´²Ö×ÁöЭ»á(CSCO)ºÚÉ«ËØÁöר¼ÒίԱ»áÖ÷ÈÎίԱ¹ù¾ü½ÌÊÚ¡£

    ÊÜ·Ãר¼Ò£º¹ù¾ü£¬Ö÷ÈÎҽʦ£¬½ÌÊÚ£¬¿ÆÖ÷ÈΣ¬²©Ê¿Éú********£¬ÏÖÈα±¾©Ö×ÁöÒ½Ôº¡¢±±¾©´óѧÁÙ´²Ö×ÁöѧԺ¸±Ôº³¤£¬±±¾©ÊÐÖ×Áö·ÀÖÎÑо¿Ëù¸±Ëù³¤£¬Éö°©ºÚÉ«ËØÁöÄÚ¿ÆÖ÷ÈΡ£ÖйúÁÙ´²Ö×ÁöЭ»á(CSCO)ִί»áίԱ£¬ÖйúÁÙ´²Ö×ÁöЭ»á(CSCO)ºÚÉ«ËØÁöר¼ÒίԱ»áÖ÷ÈÎίԱ£¬ÖйúÁÙ´²Ö×ÁöЭ»á(CSCO)Éö°©×¨¼ÒίԱ»áÖ÷ÈÎίԱ£¬Öйú¿¹°©Ð­»áÉö°©×¨ÒµÎ¯Ô±»á³£ÎñίԱ£¬ÖйúÍíÆÚÉö°©ÖÎÁÆר¼ÒίԱ»á³ÉÔ±£¬Öйú¿¹°©Ð­»áÃÚÄòÖ×Áö·Ö»á³£ÎñίԱ¡£¹ú¼ÊºÚÉ«ËØÁöר¼ÒίԱ»áGMTF(Golbal Melanoma TaskForce)ίԱ£¬¹ú¼ÊºÚÉ«ËØÁöÑо¿ÁªÃË(Society for Melanoma Research)ÑÇÌ«µØÇøÖ÷ϯ£¬¹ú¼ÊºÚÉ«ËØÁö¼à¶½Î¯Ô±»áºò²¹Î¯Ô±£¬ºÚÉ«ËØÁö¹ú¼Ê»ù½ð»á(MIF)º£Íâ×Éѯ¹ËÎÊ¡££¬NCCNÉö°©ÕïÖÎÖ¸ÄÏÖйú°æÖ´±ÊÈË£¬ÖйúºÚÉ«ËØÁöÕïÖι²Ê¶¼°ÖйúºÚÉ«ËØÁöÕïÖÎÖ¸Äϱàд×éÖ´±ÊÈË¡£¹ú¼Ò½ÌÓý²¿ ÐÂÊÀ¼ÍÓÅÐãÈ˲ÅÖ§³Ö¼Æ»®ÈëÑ¡Õߣ¬±±¾©ÊÐÊ®°ÙǧÎÀÉúÓÅÐãÈ˲Żù½ð»ñµÃÕß¡£Melanoma Research£¬Journalof Cancer Research and Clinical Oncology£¬ÖйúÖ×ÁöÁÙ´²µÈÔÓÖ¾ÌØÔ¼Éó¸åר¼Ò£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÆÀÉóר¼Ò¡£

    ¹ù¾ü¸æËß¼ÇÕߣ¬ðëÊÇÓɲúÉúÉ«ËصĺÚÉ«ËØϸ°û×é³É£¬ºÜ¶àð뿪ʼÊDZâƽµÄ£¬ºóÀ´Öð½¥Â¡Æð¡£ÔÚÉúÃüÆð³õµÄ20Ä꣬ËüÃǻ᲻¶ÏµØÉú³¤£¬¶àÊý³¤µÃºÜÂý£¬Óеij¤µ½1cm×óÓÒ»ò¸ü´ó£¬Ò²ÓеĻ᳤³öë·¢¡£Æ¤·ô°×ðªµÄÈ˸ü³£¼ûµ½ðë¡£

    ½ü¼¸Ä꣬ÖйúºÚÉ«ËØÁöµÄ·¢²¡ÂʳÊÉÏÉýÇ÷ÊÆ¡£¶àÊý¶ñÐÔºÚÉ«ËØÁöÆðÔ´ÓÚÕý³£Æ¤·ôµÄºÚÉ«ËØϸ°û£¬Ò»²¿·ÖÆðÔ´ÓÚÉ«ËØðë¡£ºÚÉ«ËØÁöÊÇƤ·ôÖ×ÁöÖжñÐԳ̶È×î¸ßµÄÁöÖÖ¡£

    ÈçºÎÅжÏÎÒµÄðëÕý³£²»Õý³£?

    

    A¡¢²»¶Ô³ÆÐÔ£¬ÆÕͨµÄºÚðëÊÇÔ²ÐλòÕßÍÖÔ²ÐΣ¬½á¹¹±È½Ï¶Ô³Æ¡£¶øÓжñ±ä¿ÉÄܵĺÚð룬ÐÎ״ͨ³£²»¹æÔò£¬²»¶Ô³Æ¡£

    B¡¢±ß½ç²»¹æÔò£¬ÓпÉÄÜ·¢Õ¹³ÉºÚÉ«ËØÁöµÄºÚð룬±ß½ç¿ÉÄܳÊÏÖ¾â³Ý×´»òÕßµØͼÑùµÄ¸Ä±ä£¬ÕâÌáʾןÚðë¿ÉÄÜÔÚÏòÖÜΧ×éÖ¯½þÈó¡¢ÇÖ·¸¡£

    

    C¡¢ÑÕÉ«²»¾ùÔÈ£¬ÆÕͨµÄºÚðëÑÕÉ«·Ö²¼±È½Ï¾ùÔÈ£¬µ«ÊǺÚÉ«ËØÁöµÄÑÕɫͨ³£²»¾ùÔÈ£¬²¢ÇÒ³ÊÏÖ¶àÖÖÑÕÉ«»ìºÏµÄÇé¿ö£¬Ö÷Òª±íÏÖΪÎÛ×ǵĺÚÉ«£¬Ò²¿ÉÓк֡¢×Ø¡¢×غڡ¢À¶¡¢·Û£¬ÉõÖÁ°×É«¡£

    D¡¢Ö±¾¶½Ï´ó£¬Ö±¾¶ÔÚ6ºÁÃ×ÒÔÉϵĺÚð룬»¼ÕßÓ¦¸*************************ÜÇй۲졣Èç¹ûºÚðë½øÒ»²½Ôö´ó£¬³¬¹ý1ÀåÃ×£¬¾ÍÓ¦¼°Ê±¾ÍÕï¡£ÒòΪֱ¾¶½Ï´óµÄºÚðë·¢Éú¶ñ±äµÄ¿ÉÄÜÐÔÃ÷ÏÔÔö¼Ó¡£Ò½ÉúÓöµ½Ö±¾¶½Ï´óµÄºÚð룬һ°ã»á½«ÆäÍêÕûÇгýË͵½²¡Àí¿ÆÕï¶ÏÁ¼¶ñÐÔ¡£

    E¡¢¾Ö²¿Â¡Æð»òÖð½¥Éú³¤£¬Èç¹ûºÚðëÔÚ¼¸¸öÔ»òÕß°ëÄêÄÚѸËÙÔö´ó£¬ÔòÐèÒªÕÒר¿ÆÒ½Éú¾ÍÕ½øÒ»²½ÅŲ顣

    

    ÄÄÖÖðë×îÈÝÒ×°©±ä?

    ¹ù¾ü±íʾ£¬Ä¿Ç°Ñо¿·¢ÏÖ£º¶àð룬ÓÈÆäÊÇÌرð¶à£¬´ÓÁ³Éϵ½ÉíÉÏÈ«¶¼Êǵģ¬µÃºÚÉ«ËØÁöµÄ·çÏÕ±ÈÆÕͨÈ˸ß40±¶¡£µ«ºÚÉ«ËØÁöÔÚÎÒ¹úµÄ·¢²¡Âʺܵͣ¬Îª0.6/10Íò¡£ËùÒÔÒ²²»Òâζ×ŶàÖ̵ÄÈËÕâ±²×ÓÒ»¶¨»áµÃ£¬µ«ÐèҪƽʱ¶à¼Ó×¢Òâ¡£

    µÚ¶þÖÖÊÇÏÈÌìÐÔ¾Þð룺´Ó³öÉú¾ÍÓУ¬Ò»´óƬ£¬¸íÀï¸í´ñµÄ£¬±íÃæÒ²²»Æ½Õû¡£ÕâÖÖÏÈÌìÐÔ¾Þð룬ÔÚ¶ùͯÆÚ×îºÃ¾ÍÓ¦¸ÃÍêÕûÇгý£¬²»ÒªÁôµ½³ÉÄêÒÔºó¡£ÎÒÃǼû¹ýÌ«¶àÌ«¶àÏÈÌìÐÔ¾ÞðëµÄ¶ñ±ä£¬¶øÇÒ¶ñ±ä³Ì¶È»¹ºÜ¸ß¡£

    Ëæ×ÅÄê¼ÍÔö´ó£¬Ã¿¸öÈËÉíÉϵÄðëºÍ°ßµã¶¼»áÂýÂýÔö¶à£¬Äĸö²¿Î»µÄºÚðëÒ»¶¨ÒªÇгý?

    ¹ù¾ü½âÊÍ£¬Ã»Óоø¶ÔµÄ˵³¤ÔÚÄĸö²¿Î»µÄºÚðëÒ»¶¨ÒªÇгý¡£´Ó·¢²¡ÂÊÀ´¿´£¬ÖйúµÄºÚÉ«ËØÁöÒ»°ëÒÔÉÏÀ´×ÔÓÚËÄÖ«Ä©¶ËµÄƤ·ô£¬Èç×ã¡¢ÊÖºÍÖ¸¼×ϵÈλÖ㬿ÉÄÜÊÇÒòΪ֫¶ËµÄƤ·ôĦ²Á¡¢ËðÉ˸ü¶à¡£ÆäËû25%ºÚÉ«ËØÁöÀ´×ÔÈ«ÉíµÄƤ·ô¡£»¹ÓÐ25%À´×ÔÓÚð¤Ä¤£¬Ïñ±ÇÇ»£¬¿ÚÇ»£¬Ê³µÀ£¬½áÖ±³¦£¬µÈ²¿Î»¡£

    µ«²»ÊÇÕâЩ²¿Î»³¤ÁËðë¾ÍÒªÇеô¡£Èç¹û²»·ÅÐÄ£¬¿ÉÒÔÕÒÓо­ÑéµÄÒ½Éú¿´Ò»ÑÛ£¬½á¹û»ù±¾·ÖÈýÖÖ¡£µÚÒ»£¬ÄúÕâ¸öÍêÈ«¿ÉÒÔ²»ÓÃÇУ¬»Ø¼ÒÈ¥¡£µÚ¶þ£¬ÄúÕâ¸ö¿ÉÇУ¬¿É²»ÇУ¬¹Û²ìÒ²¿ÉÒÔ¡£µÚÈýÖÖ£¬²»ÐУ¬ÄãµÃÂíÉÏÇУ¬Õâ¸öÓÐÌ«¸ßµÄ·çÏÕ¡£

    ¶ÔÓÚµÚ¶þÖÖÇé¿ö£¬»Ø¼ÒÐèÒª¹Û²ì¡£Èç¹û³öÏÖÁ˱߽粻Ç壬»òÕßͻȻÑÕÉ«²»¾ùÒ»£¬ÓÐÉîÓÐdz£¬»òÕßÊDZíÃæÆÆÀ£¡¢Á÷Ë®¡¢Á÷Ѫ¡£ÕâЩ¶¼ÊǶñ±äµÄÕ÷Õ×£¬Ò»¶¨Òª¼°Ê±¾ÍÕï¡£

    ÆäÖÐ×îÐèҪעÒâµÄÊÇ·¢Éú±íÃæÆÆÀ£¡¢ÑÕÉ«¸Ä±ä»òѸËÙÔö´óÈ´²»ÌÛ²»Ñ÷µÄºÚðë¡£ÌÛºÍÑ÷»¹ºÃÁË£¬ÎªÉ¶?Ñ×Ö¢£¬Ñ×Ö¢ÊǺìÖ×ÈÈÍ´£¬Ï¸¾ú¸ÐȾ¡¢²¡¶¾¸ÐȾ¡¢»òÕßÊǾֲ¿µÄÍâÉËÒýÆðµÄ¸ÐȾ£¬ËüÊǺ졢Öס¢ÈÈ¡¢Í´¶¼ÓС£°©Ö¢²ÅÊDz»ÌÛ²»Ñ÷µÄ¡£

    Èç¹ûÐèÒªÇÐð룬Ҳ²»ÄܲÉÓü¤¹â¡¢À䶳µÈÃÀÈݼ¼Êõ¡£Ò»¸öÔçÆڵĺÚÉ«ËØÁö¾­¹ý¼¤¹â¡¢À䶳µÈ´¦Àí£¬²»µ«²»Äܸù³ýºÚÉ«ËØÁö£¬·´¶ø»á°ÑºÚÉ«ËØÁö´Ódz±íµÄ±íƤ²ã´øÈëµ½ÕæƤ²ã¡£ÓÕ·¢ºÚÉ«ËØÁöתÒƺÍÀ©É¢¡£
·ÖÏí:

ÓÞÓÞѧ԰ÊôÓÚ´¿Ñ§Êõ¡¢·Ç¾­ÓªÐÔרҵÍøÕ¾£¬ÎÞÈκÎÉÌÒµÐÔÖÊ£¬´ó¼Ò³öÓÚѧϰºÍ¿ÆÑÐÄ¿µÄ½øÐн»Á÷ÌÖÂÛ¡£

ÈçÓÐÉæÇÖ·¸Öø×÷ȨÈ˵İæȨµÈÐÅÏ¢£¬Ç뼰ʱÀ´ÐŸæÖª£¬ÎÒÃǽ«Á¢¿Ì´ÓÍøÕ¾ÉÏɾ³ý£¬²¢ÏòËùÓгְæȨÕßÖÂ×îÉîǸÒ⣬лл¡£